Market revenue in 2022 | USD 230.8 million |
Market revenue in 2030 | USD 300.7 million |
Growth rate | 3.4% (CAGR from 2022 to 2030) |
Largest segment | Antibiotics |
Fastest growing segment | Antimicrobial |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antimicrobial, Antibiotics |
Key market players worldwide | Boehringer Ingelheim, CEVA Inc, Elanco Animal Health Inc, Neogen Corp, Phibro Animal Health Corp Class A, Vetoquinol SA, Virbac SA, Zoetis Inc Class A |
Antibiotics was the largest segment with a revenue share of 56.93% in 2022. Horizon Databook has segmented the Europe animal antimicrobial and antibiotics market based on antimicrobial, antibiotics covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is home to some of the world's most advanced animal husbandry practices, which include advanced breeding techniques, sophisticated housing systems, and advanced feeding practices. These practices lead to healthier animals that are less susceptible to disease, reducing the need for antibiotics and other antimicrobials.
The European Union has implemented several measures aimed at reducing the use of antibiotics in livestock, including a limitation on the use of antibiotics as growth promoters and the introduction of national action plans to reduce the use of antibiotics in animals. As a result of these measures, the market for animal antibiotics in Europe has declined in recent years.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account